COLL - CIK 0001267565
COLLEGIUM PHARMACEUTICAL, INC (COLL) reported revenue of $780.57M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $780.57M | +23.6% |
| FY 2024 | $631.45M | +11.4% |
| FY 2023 | $566.77M | +22.2% |
| FY 2022 | $463.93M | +67.6% |
| FY 2021 | $276.87M | -10.7% |
| FY 2020 | $310.02M | +4.5% |
| FY 2019 | $296.70M | +5.8% |
| FY 2018 | $280.41M | +884.7% |
| FY 2017 |
COLLEGIUM PHARMACEUTICAL, INC (COLL) reported revenue of $780.57M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2016 and fiscal 2025, COLLEGIUM PHARMACEUTICAL, INC's revenue grew from $1.71M to $780.57M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $28.48M |
| +1564.3% |
| FY 2016 | $1.71M | - |